Saúl Campos-Gómez

2.4k total citations · 1 hit paper
35 papers, 780 citations indexed

About

Saúl Campos-Gómez is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Saúl Campos-Gómez has authored 35 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Saúl Campos-Gómez's work include Advanced Breast Cancer Therapies (12 papers), Cancer Treatment and Pharmacology (10 papers) and Lung Cancer Research Studies (6 papers). Saúl Campos-Gómez is often cited by papers focused on Advanced Breast Cancer Therapies (12 papers), Cancer Treatment and Pharmacology (10 papers) and Lung Cancer Research Studies (6 papers). Saúl Campos-Gómez collaborates with scholars based in Mexico, United States and South Korea. Saúl Campos-Gómez's co-authors include Aditya Bardia, Joohyuk Sohn, Fábio Franke, Nadia Harbeck, Louis W.C. Chow, Marco Colleoni, Debu Tripathy, Yen‐Shen Lu, Tetiana Taran and Sara A. Hurvitz and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Saúl Campos-Gómez

32 papers receiving 759 citations

Hit Papers

Overall Survival with Ribociclib plus Endocrine Therapy i... 2019 2026 2021 2023 2019 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer
    2019 591 citations Seock‐Ah Im, Yen‐Shen Lu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saúl Campos-Gómez Mexico 9 624 566 281 162 99 35 780
Aurelio Castrellon United States 12 392 0.6× 429 0.8× 210 0.7× 125 0.8× 102 1.0× 34 655
S.-A. Im South Korea 12 271 0.4× 478 0.8× 159 0.6× 58 0.4× 93 0.9× 39 686
Joanne Cox United States 6 525 0.8× 430 0.8× 170 0.6× 214 1.3× 32 0.3× 13 638
J.M. Sánchez-Torres Spain 13 428 0.7× 614 1.1× 104 0.4× 42 0.3× 150 1.5× 21 772
Lydia Dreosti South Africa 10 179 0.3× 300 0.5× 75 0.3× 61 0.4× 157 1.6× 20 472
Delphine Topart France 12 234 0.4× 425 0.8× 231 0.8× 27 0.2× 122 1.2× 29 606
Amy Prawira Canada 11 147 0.2× 326 0.6× 111 0.4× 48 0.3× 172 1.7× 38 621
Julio A. Peguero United States 12 241 0.4× 368 0.7× 78 0.3× 28 0.2× 133 1.3× 49 517
Y. Ko Germany 6 185 0.3× 221 0.4× 67 0.2× 48 0.3× 117 1.2× 13 490
Johann Raats South Africa 9 280 0.4× 367 0.6× 83 0.3× 35 0.2× 188 1.9× 15 569

Countries citing papers authored by Saúl Campos-Gómez

Since Specialization
Citations

This map shows the geographic impact of Saúl Campos-Gómez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saúl Campos-Gómez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saúl Campos-Gómez more than expected).

Fields of papers citing papers by Saúl Campos-Gómez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saúl Campos-Gómez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saúl Campos-Gómez. The network helps show where Saúl Campos-Gómez may publish in the future.

Co-authorship network of co-authors of Saúl Campos-Gómez

This figure shows the co-authorship network connecting the top 25 collaborators of Saúl Campos-Gómez. A scholar is included among the top collaborators of Saúl Campos-Gómez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saúl Campos-Gómez. Saúl Campos-Gómez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bourlon, María T., et al.. (2023). Impact of healthcare inequities on survival in Mexican patients with metastatic renal cell carcinoma. Frontiers in Oncology. 13. 1 indexed citations
2.
3.
4.
5.
Soto‐Pérez‐de‐Celis, Enrique, Óscar Arrieta, Enrique Bargalló‐Rocha, et al.. (2021). COVID-19 Vaccine Guidance for Patients with Cancer in Mexico: Report From the Working Group of the Mexican Society of Oncology. Archives of Medical Research. 53(2). 223–227. 1 indexed citations
6.
Barrón, Feliciano, Andrés F. Cardona, Saúl Campos-Gómez, et al.. (2020). Brigatinib in ALK -positive non-small cell lung cancer: real-world data in the Latin American population (Bri-world extend CLICaP). Future Oncology. 17(2). 169–181. 7 indexed citations
7.
Hurvitz, Sara A., Guy Jérusalem, S-A. Im, et al.. (2020). 329P Ribociclib (RIB) in patients (pts) with HR+/HER2− advanced breast cancer (ABC) and resistance to prior endocrine therapy (ET) in the MONALEESA (ML) -3 and -7 trials. Annals of Oncology. 31. S376–S377. 3 indexed citations
8.
Campos-Gómez, Saúl, et al.. (2019). Inulin Supplementation Reduces Systolic Blood Pressure in Women with Breast Cancer Undergoing Neoadjuvant Chemotherapy. Cardiovascular Therapeutics. 2019. 1–10. 19 indexed citations
9.
Campos-Gómez, Saúl, et al.. (2019). Treatment Patterns and Costs Associated with Stage IV Non-Small Cell Lung Cancer in a Mexican Population: A Chart Review. PharmacoEconomics - Open. 4(2). 381–388.
10.
Hurvitz, Sara A., Seock‐Ah Im, Yen‐Shen Lu, et al.. (2019). Phase III MONALEESA-7 trial of premenopausal patients with HR+/HER2− advanced breast cancer (ABC) treated with endocrine therapy ± ribociclib: Overall survival (OS) results.. Journal of Clinical Oncology. 37(18_suppl). LBA1008–LBA1008. 21 indexed citations
11.
Beck, J. Thaddeus, Patrick Neven, Joohyuk Sohn, et al.. (2019). Abstract P6-18-06: Ribociclib treatment benefit in patients with advanced breast cancer with ≥1 dose reduction: Data from the MONALEESA-2, -3, and -7 trials. Cancer Research. 79(4_Supplement). P6–18. 6 indexed citations
12.
Muniz, David Queiroz Borges, Hongbo Yang, James Signorovitch, et al.. (2019). Real-World Effectiveness and Tolerability of Pazopanib as First Targeted Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Chart Review in Latin America. Advances in Therapy. 36(12). 3446–3457. 2 indexed citations
13.
14.
Hernández‐Garduño, Eduardo, et al.. (2017). Prevalence trends of wood use as the main cooking fuel in Mexico, 1990-2013. Salud Pública de México. 59(1). 68–68. 12 indexed citations
15.
Campos-Gómez, Saúl, et al.. (2016). Neoadjuvant carboplatin and docetaxel in locally advanced triple negative breast cancer: A Hispanic trial.. Journal of Clinical Oncology. 34(15_suppl). e12554–e12554. 1 indexed citations
16.
Campos-Gómez, Saúl, et al.. (2015). Safety and efficacy of scalp hypothermia to prevent chemotherapy-induced alopecia: A study of a scalp-cooling system used in breast cancer women in a Mexican public hospital.. Journal of Clinical Oncology. 33(15_suppl). e12021–e12021. 1 indexed citations
17.
Campos-Gómez, Saúl, Humberto Lara-Guerra, Mark J. Routbort, Xinyan Lu, & George R. Simon. (2015). Lung adenocarcinoma with Concurrent KRAS Mutation and ALK Rearrangement Responding to Crizotinib: Case Report. The International Journal of Biological Markers. 30(2). 254–257. 12 indexed citations
18.
Campos-Gómez, Saúl, et al.. (2014). Pretreatment platelets count levels as a prognostic factor in triple-negative breast cancer in a Hispanic cohort.. Journal of Clinical Oncology. 32(15_suppl). 1115–1115. 1 indexed citations
19.
Campos-Gómez, Saúl, et al.. (2014). Case report: anti-hormonal therapy in the treatment of ductal carcinoma of the parotid gland. BMC Cancer. 14(1). 701–701. 8 indexed citations
20.
Campos-Gómez, Saúl, et al.. (2008). Métodos utilizados como nefroprotección en pacientes sometidos a estudios con medios de contraste. 5(14). 4–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aurelio Castrellon Breakdown of academic impact, for papers by S.-A. Im Breakdown of academic impact, for papers by Joanne Cox Breakdown of academic impact, for papers by J.M. Sánchez-Torres Breakdown of academic impact, for papers by Lydia Dreosti Breakdown of academic impact, for papers by Delphine Topart Breakdown of academic impact, for papers by Amy Prawira Breakdown of academic impact, for papers by Julio A. Peguero Breakdown of academic impact, for papers by Y. Ko Breakdown of academic impact, for papers by Johann Raats
Rankless by CCL
2026